Multiple sclerosis: recent advances in diagnosis clinical immunology and virology.
作者信息
Paty D W
出版信息
Can Med Assoc J. 1977 Jul 23;117(2):113-4.
Abstract
摘要
相似文献
1
Multiple sclerosis: recent advances in diagnosis clinical immunology and virology.
Can Med Assoc J. 1977 Jul 23;117(2):113-4.
2
Immunology of multiple sclerosis.
Curr Opin Neurol Neurosurg. 1992 Apr;5(2):195-202.
3
Recent advances in clinical diagnosis of multiple sclerosis.
J Tenn Med Assoc. 1980 Oct;73(10):714-6.
4
In pursuit of quarry, MS researchers draw on immunology, virology advances.
JAMA. 1986 Aug 15;256(7):809-11, 815-6. doi: 10.1001/jama.256.7.809.
5
Acinetobacter immune responses in multiple sclerosis: etiopathogenetic role and its possible use as a diagnostic marker.
Arch Neurol. 2005 Jan;62(1):33-6. doi: 10.1001/archneur.62.1.33.
6
[The latest world standards in the diagnosis of multiple sclerosis].
Klin Oczna. 2009;111(1-3):70-4.
7
Proceedings: Morphology of multiple sclerosis.
Acta Neurochir (Wien). 1975;31(3-4):290-1.
8
[Disseminated sclerosis and slow virus diseases (author's transl)].
Acta Neurol Belg. 1973 May-Jun;73(3):165-74.
9
Neuroimaging in multiple sclerosis.
Neurol Clin. 1995 Feb;13(1):147-71.
10
Toward biomarkers in multiple sclerosis: new advances.
Expert Rev Neurother. 2006 May;6(5):781-94. doi: 10.1586/14737175.6.5.781.
引用本文的文献
1
Abnormal protein patterns in multiple sclerosis.
Neurochem Res. 1979 Dec;4(6):811-20. doi: 10.1007/BF00964477.
本文引用的文献
1
PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.
Ann N Y Acad Sci. 1965 Mar 31;122:552-68. doi: 10.1111/j.1749-6632.1965.tb20235.x.
2
Studies on the natural history of multiple sclerosis. V. Long-term survival in young men.
Arch Neurol. 1970 Mar;22(3):215-25. doi: 10.1001/archneur.1970.00480210025003.
3
Alteration of the orbicularis oculi reflex by pontine lesions. Study in multiple sclerosis.
Arch Neurol. 1970 Feb;22(2):156-61. doi: 10.1001/archneur.1970.00480200062006.
4
Immunoglobulins in multiple sclerosis and infections of the nervous system.
Arch Neurol. 1971 Oct;25(4):326-44. doi: 10.1001/archneur.1971.00490040052007.
5
Double-blind trial of linoleate supplementation of the diet in multiple sclerosis.
Br Med J. 1973 Mar 31;1(5856):765-8. doi: 10.1136/bmj.1.5856.765.
6
Intensive immunosuppression in the treatment of multiple sclerosis.
Lancet. 1974 Nov 9;2(7889):1093-6. doi: 10.1016/s0140-6736(74)90866-6.
7
Histocompatibility determinants in multiple sclerosis, with special reference to clinical course.
Lancet. 1973 Dec 1;2(7840):1221-5. doi: 10.1016/s0140-6736(73)90970-7.
8
Letter: Transfer-factor therapy in multiple sclerosis.
Lancet. 1973 Dec 15;2(7842):1381-2. doi: 10.1016/s0140-6736(73)93339-4.
9
Delayed visual evoked response in optic neuritis.
Lancet. 1972 May 6;1(7758):982-5. doi: 10.1016/s0140-6736(72)91155-5.
10
Multiple sclerosis-associated agent: transmission to animals and some properties of the agent.
Infect Immun. 1975 Dec;12(6):1355-66. doi: 10.1128/iai.12.6.1355-1366.1975.
Zotero 插件